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Abstract


This thesis entitled “Studies towards the induction of helicity in β-hGly oligomers: synthesis of novel pyran β-amino acid, its peptides, (-)-swainsonine and epi-swainsonine” is divided into three chapters. First chapter mainly describes the induction of 12/10-mixed helical pattern in the β-hGly rich oligomers, wherein, the helicity in such oligomers was induced by capping with (R)-β-Caa residue and robust helical tripeptide motifs. Second chapter is dealt with the synthesis of novel pyran amino acid [amino pyran carboxylic acid (APyC)], its homo oligomers and a series of /-hybrid peptides with alternating D-alanine, besides their conformational studies by extensive NMR spectroscopy, Molecular Dynamics (MD) and Circular Dichroism (CD) studies. Third chapter describes an effective formal synthesis of (-) swainsonine and epi-swainsonine from the potential monocyclic oxazolidinone intermediate.

Chapter I: Synthesis of -Peptides: Induction of Helicity in -hGly Oligomers 
The development of non-natural polymers that fold into compact and specific conformations is required in order to design and develop molecules with useful biological functions. In order to throw more light on this feature of foldamers, an investigation was undertaken on short -alanine (-hGly) rich -peptides, which are known not to form secondary structures. 
Proteins though adopt compact folding patterns and participate in a wide variety of functions, have intrinsically flexible backbones.1 The functions of proteins throw challenges to the chemists in designing of peptides that can adopt and propagate novel conformational features. β-Amino acids are part structures of several natural products and their importance and nonavailability from ‘chiral pool’ prompted the development of new and efficient strategies2 for their synthesis, enroute` to peptidomimetics. Seebach et al.3 and Gellman et al.4 were the first to report β-peptides with novel helical structures, followed by subsequent reports on a variety of novel secondary structures in β-peptides with different designs, which led to the development of ‘foldamers’.
The initial attempts towards the synthesis of β-hGly oligomers in solution phase met with limited success, mainly due to the inadequacies arising from their solubility. To circumvent the problem associated with the solubility, diacetone galactose was used as ester protecting group at the C-terminus and achieved the synthesis of tri-2, tetra-3 and pentapeptides 4 (Scheme 1), in the presence of  EDCI and HOBt5, with DIPEA as a base in dry CH2Cl2. The 1H NMR spectrum of peptide 2 showed distinctly different chemical shifts for protons at Cα and Cβ of the third β-hGly residue. Very similar behavior was observed for peptide 3, while, drastic change in the 1H NMR spectrum of 4 was observed, wherein isomeric species were observed in 70:30 ratio. For the major isomer, a small population of the molecule participated in H-bonding, while for the minor isomer, the second to fifth residues respectively supported their participation in H-bonding. This could be attributed to the chiral induction by galactose group. This observation prompted us to use C-linked-carbo-β-amino acid (R)-β-Caa (5) as a chiral unit for the helical induction.
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Accordingly, the requisite (R)-β-Caa (5) was prepared from 6. Thus, reaction of 6 (Scheme 2), with benzyl amine (2.5 equivalents)6 at room temperature gave esters 7 (39%) and 8 (24%). The esters 7 and 8 were subjected to hydrogenolysis (10% Pd-C) in methanol under hydrogen atmosphere and subsequent reaction of 9 and 10 with (Boc)2O and Et3N in THF to afforded 11 (92%) and 5 (89%). Further, 11 and 5 on hydrolysis with NaOH in methanol gave acids 12 (94%) and 14 (92%) respectively, while, treatment with trifluroacetic acid (TFA) in CH2Cl2 furnished the respective TFA salts 13 and 15. 
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The peptides 16, 17 and 18/19 respectively capped at C-, N- and C- and N-termini with (R)-β-Caa were prepared in the presence of EDCI, HOBt and DIPEA in CH2Cl2. The 1H NMR spectrum of 16 appeared very similar to that of 4, because of the presence of two isomers in 1:2 ratio. However, a careful study of 16 showed H-bonding with a 12/10-helical pattern for the major isomer, while for 17, the major isomer, displayed a 12/10-helical pattern in a slightly larger population of ~70%. 
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However, for pentapeptide 18, the population of the major isomer increased to about 95%, involving in H-bonding with a 12/10-helical pattern, while 19 showed a very similar trend as was observed for peptide 18, with a population of the major isomer about 92%. 
Having induced helicity with (R)-β-Caa residue, in a further study it was proposed to use tripeptide 20 to induce helicity. Peptides 21, 22, 23 and 24 were synthesized in the presence of EDCI, HOBt and DIPEA in dry CH2Cl2 (Scheme 4). 
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The 1H NMR spectrum of 21 revealed two isomers in the ratio of 70:30. These results show that the major isomer contains all the signatures of a 12/10-helix. Though, for the minor isomer, several H-bonded amide protons were observed, it was not possible to get many details on its structure. The NMR (CDCl3) studies on 22, revealed similar results with two isomers in a ratio of 75:25. The conformational multiplicity, in the form of the major and minor isomeric species, thus provides evidence for the destabilization of the 12/10-helices in these β-hGly oligomers ends capped at the C-termini. 

	
        
                             Figure 1. CD spectra of peptides 21, 22, 23 and 24 in MeOH.

Similarly, peptides 23 and 24 displayed all the characteristic signatures for the presence and propagation of 12/10-mixed helix. Unlike in 21 and 22, the populations of the minor isomers was too small to be determined (being below the detection limit). Further, CD-spectral analysis (Figure 1) evidently revealed that the nucleation from the N-terminus leads into robust helical patterns, while, the same is not true with the nucleation from the C-terminus.
For a further study, peptides 25, 26 and 27 “helix capped” at both the C- and N-termini were synthesized. 
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                                Figure 2. CD spectra of peptides 25, 26 and 27 in MeOH

The NMR (in CDCl3) studies of 25, 26 and 27 indicated the propagation of the 12/10-mixed helical pattern. In 25 and 26, it very clearly emerged that (β-hGly)3 and (β-hGly)5 segments end capped between the two 12/10-helices in the termini gets accommodated in an elongated helix with a 12/10 H-bonded configuration. For peptide 27, however, though there was a severe overlap, similar propagation of 12/10-helix, further shows that as many as seven consecutive β-hGly residues are held in a 12/10-helical fold by the end capping with two robust helices.

Chapter II: Design and synthesis of novel pyran β-amino acid and its peptides 
Gellman et al.4 reported that enantiopure short chain -peptides with appropriate substitution pattern, could fold in a predictable manner into a highly stable and new type of helical secondary structures. Further, Gellman et al.7 reported  /-peptides containing amino cyclopentane carboxylic acid (ACPC) and amino cyclohexane carboxylic acid (ACHC) residues alternating with -amino acids. The ACPC containing /-peptides showed strong evidence for a 14/15- folded conformation, while the ACHC containing /-peptides did not show support for the presence of a helix formation. 
This instigated us to design and synthesize a new β-amino acid, amino pyran carboxylic acid (APyC) 28. The design of this monomer was mainly aimed to change the dihedral angles of 6-membered ring by the insertion of oxygen (conversion of cyclohexane ring into pyran ring), and see the role of oxygen in stabilization of the helix and solubility. The β-amino acid 28 was used in different designs for peptide synthesis. 






  

Accordingly, aldehyde 29 was converted into known 1,2-amino diol8 30 in 76% yield (Scheme 6). Treatment of diol 30 with TBSCl in the presence of imidazole and reaction of 31 with allyl bromide (NaH, DMF) afforded the allyl ether 32. RCM reaction on diene 32 in toluene at reflux for 8 h in the presence of Grubb’s catalyst9 I (5 mol%)  afforded 33. 
Scheme 6










Debenzylation of 33 under Birch reaction conditions (Li, Liq NH3) at -78 °C in THF for 1 h afforded the amide 34, which on hydrogenation with 10% Pd-C in MeOH under hydrogen atmosphere gave 35. Sequential oxidation of alcohol 35 under Swern reaction conditions followed by further oxidation of aldehyde 36 using NaClO2 and 30% H2O2 in t-BuOH:H2O furnished the acid 36a, which was then converted into its methyl ester 28 on treatment with diazomethane.
In the initial study, homo-oligomers 37-39 were prepared from 28. The 1H NMR and CD-spectral data indicated the presence of signatures of secondary structures in 38 and 39. However, due to severe overlap of peaks as well as presence of strong exchange peaks in the 1H NMR spectrum, information on the structure of the helix could not be derived. 
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In a further study, α/β-peptides 40-42 were prepared from 1:1 alteration of 28 with D-Ala. In dipeptide 40, the nOe correlation between CβH/NH(2) and CεH/NH(2) confirm the presence of novel 5-membered H-bond between NH(2) and pyran oxygen of β(1), which is similar to that reported by Grierson et al.10 
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Figure 3: A) Circular dichroism spectrum of 42 in CH3OH at concentration of 0.2 mM. B) Superimposed 25 minimum energy structures of 42

Further, the 1H NMR of tetrapeptide 41 in CDCl3 showed 9/11-helix, besides NH(2) simultaneously participating in a forward 9-mr H-bonding with CO(3) and a 5-mr H-bonding with pyran oxygen of β(1). (Novel bifurcated 5-membered helix along with 9-membered helix). Similar results were observed in hexapeptide 42. 
In a further study, /β-peptides 43-47 were prepared. In dipeptide 43, presence of 5-membered H-bonding was not observed. In tetrapeptide 44, the nOe correlations support bifurcated 9/5- hydrogen bonding between NH(3)-CO(4), NH(3)-O of third pyran residue, while, characteristic nOes supported 9/11-helix. Similar results were observed in hexapeptide 45. Similar H-bonding pattern was found in peptides 46 and 47. 
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Figure 4: A) Circular dichroism spectrum of 44 in CH3OH at concentration of 0.2 mM. B) Superimposed 25 minimum energy structures of 44 




















Chapter III: Formal synthesis of (-)-swainsonine and (+)-1,2-Di-epi-swainsonine
(-)-Swainsonine and analogues are potentially useful anti-metastasis drugs for the treatment of cancer.11 Numerous total syntheses of naturally occurring (-)-swainsonine12 and its non-natural enantiomer (+)-swainsonine13-15 have been though reported, these molecules and their analogues are still popular targets to develop new synthetic strategies and methodologies. 
A report on the effective formal synthesis of (-)-swainsonine (48) and (+)-1,2-Di-epi-swainsonine (49) starting from inexpensive (R)-2,3-O-isopropylidene-D-glyceraldehyde 29 in 15 overall steps is presented. The present strategy and retrosynthesis of swainsonine and its epimer is shown in Scheme 10.
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Thus, the potential monocyclic oxazolidinone intermediate 51 could be prepared from the known aldehyde 29 in 5 steps. This cyclic intermediate was observed as a byproduct during the synthesis of pyran amino acid. It was felt that the cyclic precursor 51 is a very interesting precursor because a) it is a trans-aminol system, b) the -OH and -NH2 functionalities are masked as carbamate and c) both ends are differently functionalized such as a -CH2OTBS on one side and an olefin on the other side. This will facilitate for an efficient functional group transformations. 
Alcohol 318 was subjected to cyclisation in the presence of NaH in DMF at 0 °C to room temperature for 2 h to afford 51 (85%). Debenzylation of cyclic carbamate 51 under Birch reaction conditions (Li, Liq NH3, -78 °C) in THF for 1 h furnished the amide 52 in 62 % yield. Carbamate 52 was subjected to N-allylation (Scheme 11) with allyl bromide in the presence of NaH in THF:DMF (1:1) to give 53 (81%). The bis-olefin 53 in a highly diluted solution of anhydrous degassed CH2Cl2 was subjected to RCM reaction in the presence of Grubbs' catalyst II (5 mol%) to afford 50 (80%). 
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Syn-dihydroxylation of the olefin 50 under Sharpless asymmetric dihydroxylation                                  (AD-mix-α, methanesulfonamide) in t-BuOH/H2O (1:1) at 0 °C for 48 h  afforded inseparable mixture of diastereomeric diols 54 in 79% yield, which on reaction with 2,2-dimethoxypropane in acetone in the presence of cat. PTSA gave compounds 55 and 56 in with a diastereomeric ratio of 4:1. 
Likewise, Syn-dihydroxylation of 50 with OsO4 and NMO in acetone/H2O (9:1) for 12 h afforded inseparable mixture of diols 54 in 92% yield. Protection of 54 as above, afforded 55 and 56 in good yields with a ratio 1.5:1. 
Desilylation of 55 with TBAF followed by oxidation of 57 with Dess-Martin periodinane in dry CH2Cl2 furnished aldehyde 58 (Scheme 12), which on Wittig olefination with (methoxycarbonylmethylene)triphenyl phosphorane in benzene at reflux for 2 h gave esters 59 in 86% yield (E:Z ratio 9:1). 
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	The mixture of esters 59 were subjected to hydrogenation in the presence of catalytic amount of PtO2 and H2 gas (40 psi) in EtOAc at room temperature for 6 h to furnish saturated ester 60 (96%), which on cyclisation in a pressure tube in the presence of 6M NaOH at 120 oC in methanol afforded the amide 61 (46%), []D + 4.0 (c 0.16, MeOH). lit.16 []D + 4.3 (c 0.16, MeOH); The IR, mass and 1H NMR data of the synthetic amide 61 was in good accordance with those of the reported values.16 This step involves 3 consecutive reactions viz. ester hydrolysis, oxazolidinone hydrolysis followed by cyclisation.	
            Similar sequence of synthetic transformations on minor diastereomer 56 afforded 66 in 51% yield (Scheme 13). []D - 16.0 (c 0.10, MeOH); lit.16 []D - 19.0 (c 0.10, MeOH). The IR, mass and 1H NMR data of the synthetic compound 66 were in good accordance with those of the reported values. Thus, this synthesis formally constitutes the total synthesis of 48 and 49. 
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Figure 5: A) Circular dichroism spectrum of 46 in CH3OH at concentration of 0.2 mM. B) Superimposed 25 minimum energy structures of 46 
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